-
Uncategorized1 month ago
Astellas touts data from early test of stem cell-derived eye therapy
Astellas touts data from early test of stem cell-derived eye therapy
-
Uncategorized1 month agoFrom Sequence to Patient in Under 12 Months: A Case Study in Advancing Complex Cancer Immunotherapies
Register Now Joseph Shultz Vice President of Technical Development and ManufacturingOttimo Pharma View Bio Panelist Joseph Shultz Joseph Shultz is the vice president of technical development...
-
Uncategorized1 month ago
G-Link CAR-T Delivery Platform Showcased at ASGCT
Vyriad reports that it will showcase its latest CAR T delivery technology platform, G-Link, through a schedule of presentations, technical sessions, and exhibition activities at ASGCT....
-
Uncategorized1 month agoSarepta tumbles as its gene therapy sales decline further
Even though Elevidys beat Wall Street expectations, analysts expect investor focus to shift toward Sarepta’s early-stage RNA drugs.
-
Uncategorized1 month agoKey takeaways from WHO briefing on hantavirus cruise ship outbreak
The MV Hondius, the cruise ship that has garnered global attention because of an apparent outbreak of person-to-person spread hantavirus infections, is on the move. At...
-
Uncategorized1 month ago
Human Antibodies Identified That Have Potential To Prevent and Treat Measles Virus
Scientists at La Jolla Institute for Immunology (LJI) say they are the first in the world to characterize human monoclonal antibodies (mAbs) capable of neutralizing measles...
-
Uncategorized1 month agoDigital PCR Playbook: Applications and Challenges Across Research and Clinical Labs
Register Now Alex Zevin, PhD Director, Genomics Shared ResourceFred Hutchinson Cancer Center View Bio Panelist Alex Zevin, PhD Alex Zevin, PhD, began serving as the director...
-
Uncategorized1 month agoSeaport’s IPO adventure, obesity pill battles, and Makary’s troubles
On this week’s episode of “The Readout LOUD,” we chat with Seaport Therapeutics CEO Daphne Zohar, fresh off the biotech’s successful IPO. Plus, Elaine, Allison, and...
-
Uncategorized1 month agoScience is becoming less disruptive. Is an aging workforce to blame?
Physicist Albert Einstein, widely regarded as one of the most prolific scientists of the past century, conducted much of his transformative work at the beginning of...
-
Uncategorized1 month ago
FDA pilots AI-informed one-day facility inspections
Implemented as part of a broader initiative to make more targeted and efficient use of inspection resources, the pilot program will use artificial intelligence to enable...
